WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
CLSI brings together the worldwide laboratory community to advance a common cause.
Coming April 29!
Don't miss this unique opportunity to get prepared and stay ahead of regulatory changes. This event will address FDA oversight and regulatory requirements for LDTs as well as manufacturers.
Register by March 15 to receive early bird discount price!
CLSI M100 Update Webinar 2025: Implement CLSI M100 With Confidence
Date: Wednesday, 26 February 2025 at 1:00-2:30 ET
Receive the latest guidance for implementing new breakpoints and standards into your laboratory practices, including discussion of the major changes in this edition, including:
CLSI PRE02 provides procedures for the collection of diagnostic venous blood specimens, including line draws, blood culture collection, and venipuncture in children.
CLSI MM23 covers the current state of molecular diagnostic methods intended for characterization of solid tumors and covers a range of clinical applications, including diagnosis, prognosis, therapeutic response prediction for available drugs and drugs still in clinical trials, monitoring, and presymptomatic and predisposition testing.
CLSI M100-Ed35 includes updated tables for the Clinical and Laboratory Standards Institute antimicrobial susceptibility testing standards CLSI M02| Performance Standards for Antimicrobial Disk Susceptibility Tests, 14th Edition (2024), CLSI M07| Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 12th Edition (2024), and CLSI M11 | Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 9th Edition (2018).
CLSI GP40 provides guidelines on water purified for medical laboratory use, methods for monitoring water quality and testing for specific contaminants, and water system design considerations.
CLSI M64 includes recommendations for implementing nomenclature changes for medically important bacteria and fungi that are identified and reported from clinical specimens, especially when testing for antimicrobial susceptibility.
CLSI and our volunteer members actively identify and develop new guidance on standards that raise laboratory testing quality, safety, and efficiency. We are setting the bar for how that guidance is delivered.
Learn more